ITRM20000491A0 - Formulazione farmaceutica di propionato di fluticasone. - Google Patents

Formulazione farmaceutica di propionato di fluticasone.

Info

Publication number
ITRM20000491A0
ITRM20000491A0 IT2000RM000491A ITRM20000491A ITRM20000491A0 IT RM20000491 A0 ITRM20000491 A0 IT RM20000491A0 IT 2000RM000491 A IT2000RM000491 A IT 2000RM000491A IT RM20000491 A ITRM20000491 A IT RM20000491A IT RM20000491 A0 ITRM20000491 A0 IT RM20000491A0
Authority
IT
Italy
Prior art keywords
pharmaceutical formulation
fluticasone propionate
fluticasone
propionate
formulation
Prior art date
Application number
IT2000RM000491A
Other languages
English (en)
Inventor
Alan Leslie Cripps
Paul Johnson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITRM20000491(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9921396.9A external-priority patent/GB9921396D0/en
Priority claimed from GB0014451A external-priority patent/GB0014451D0/en
Priority claimed from GB0018654A external-priority patent/GB0018654D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ITRM20000491A0 publication Critical patent/ITRM20000491A0/it
Publication of ITRM20000491A1 publication Critical patent/ITRM20000491A1/it
Application granted granted Critical
Publication of IT1317904B1 publication Critical patent/IT1317904B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IT2000RM000491A 1999-09-11 2000-09-11 Formulazione farmaceutica di propionato di fluticasone. IT1317904B1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9921396.9A GB9921396D0 (en) 1999-09-11 1999-09-11 Pharmaceutical formulation
GB0014451A GB0014451D0 (en) 2000-06-13 2000-06-13 Pharmaceutical formulation
GB0018654A GB0018654D0 (en) 2000-07-28 2000-07-28 Pharmaceutical formulation

Publications (3)

Publication Number Publication Date
ITRM20000491A0 true ITRM20000491A0 (it) 2000-09-11
ITRM20000491A1 ITRM20000491A1 (it) 2002-03-11
IT1317904B1 IT1317904B1 (it) 2003-07-15

Family

ID=27255761

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000491A IT1317904B1 (it) 1999-09-11 2000-09-11 Formulazione farmaceutica di propionato di fluticasone.

Country Status (12)

Country Link
US (4) US6479035B1 (it)
EP (1) EP1143930B8 (it)
JP (1) JP2003509359A (it)
AT (1) ATE343374T1 (it)
AU (1) AU7026800A (it)
CA (1) CA2317999C (it)
DE (1) DE60031504T2 (it)
ES (1) ES2274803T3 (it)
FR (4) FR2798290B1 (it)
GB (1) GB2354007B (it)
IT (1) IT1317904B1 (it)
WO (1) WO2001019342A2 (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9814717D0 (en) * 1998-02-23 1998-09-02 Bespak Plc Improvements in drug delivery devices
WO2001019342A2 (en) * 1999-09-11 2001-03-22 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
EP1248597B1 (en) * 1999-12-24 2005-03-30 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
EP1321159A1 (en) * 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
JP5082033B2 (ja) 2001-12-21 2012-11-28 エグゼリクシス パテント カンパニー エルエルシー Ｌｘｒのモジュレーター
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
MEP30108A (en) * 2002-03-01 2010-06-10 Chiesi Farmaceutici S P Formoterol superfine formulation
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
CN101448506A (zh) * 2005-12-02 2009-06-03 拜尔健康护理有限责任公司 通过抑制有丝分裂酶激酶治疗癌症的吡咯并三嗪衍生物
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
DE202010018594U1 (de) 2009-10-01 2018-02-16 Adare Pharmaceuticals, Inc. Oral verabreichte Kortikosteroidzusammensetzungen
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
CN102379846B (zh) * 2011-10-21 2014-07-02 江苏长风药业有限公司 以氢氟烷烃和聚乙二醇为辅料氟替卡松丙酸酯气雾剂制剂
CN104350063B (zh) 2012-05-08 2018-01-05 尼科斯眼药公司 疏水性治疗剂的制剂、其制备方法及应用
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
ES2946899T3 (es) 2019-09-26 2023-07-27 Presspart Mfg S A Herramienta de moldeo por inyección para cuerpos de inhalador de dosis medida y partes del cuerpo
US20230271770A1 (en) * 2020-04-21 2023-08-31 Amphastar Pharmaceuticals, Inc. Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL289785A (it) * 1962-11-29
CH634480A5 (de) * 1977-11-25 1983-02-15 Schwarzkopf Gmbh Hans Unter druck stehendes aerosolpraeparat.
DE2949933A1 (de) 1979-12-12 1981-06-19 Wabco Fahrzeugbremsen Gmbh, 3000 Hannover Vorrichtung zum verhindern von schlingerbewegungen eines anhaengers
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB2235627B (en) 1989-09-08 1993-09-01 Glaxo Group Ltd Inhalation medicaments for treating respiratory disorders
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5919827A (en) 1990-07-11 1999-07-06 Sepracor Inc. Method for treating asthma using optically pure R(-) salmeterol
WO1992006675A1 (en) 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5683676A (en) 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
ATE128350T1 (de) 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
DK0673240T3 (da) 1992-12-09 1999-10-11 Boehringer Ingelheim Pharma Stabiliserede medicinske aerosolopløsningsformuleringer
GB9313650D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
HU219899B (hu) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban
ES2244008T3 (es) * 1996-12-04 2005-12-01 Link Products Limited Composiciones farmaceuticas y dispositivos para su administracion.
WO1998034595A1 (de) * 1997-02-05 1998-08-13 Jago Research Ag Medizinische aerosolformulierungen
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
ATE245588T1 (de) 1998-04-30 2003-08-15 3M Innovative Properties Co Dosierventil für pharmazeutisches aerosol
CZ300910B6 (cs) 1998-06-18 2009-09-09 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostredek
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
JP4570251B2 (ja) * 1998-07-24 2010-10-27 ヤゴテック アーゲー 医薬用エーロゾル製剤
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9903759D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
US6231519B1 (en) * 1999-05-04 2001-05-15 Nokia Corporation Method and apparatus for providing air quality analysis based on human reactions and clustering methods
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
WO2001019342A2 (en) * 1999-09-11 2001-03-22 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
ATE286716T1 (de) 1999-11-23 2005-01-15 Glaxo Group Ltd Pharmazeutische formulierungen enthaltend salmeterol
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler

Also Published As

Publication number Publication date
US20040037783A1 (en) 2004-02-26
DE60031504T2 (de) 2007-04-05
EP1143930A2 (en) 2001-10-17
FR2820322B1 (fr) 2005-03-11
US6479035B1 (en) 2002-11-12
FR2848453B1 (fr) 2010-09-03
FR2798290B1 (fr) 2003-09-12
GB2354007B (en) 2003-10-22
WO2001019342A2 (en) 2001-03-22
EP1143930A3 (en) 2002-09-11
FR2848453A1 (fr) 2004-06-18
GB0022222D0 (en) 2000-10-25
CA2317999A1 (en) 2001-03-11
EP1143930B8 (en) 2008-03-19
US20030086876A1 (en) 2003-05-08
FR2843882A1 (fr) 2004-03-05
CA2317999C (en) 2004-11-09
ES2274803T3 (es) 2007-06-01
US6630129B2 (en) 2003-10-07
IT1317904B1 (it) 2003-07-15
DE60031504D1 (de) 2006-12-07
WO2001019342A3 (en) 2001-08-09
FR2798290A1 (fr) 2001-03-16
AU7026800A (en) 2001-04-17
FR2843882B1 (fr) 2011-04-22
EP1143930B1 (en) 2006-10-25
US7220403B2 (en) 2007-05-22
GB2354007A (en) 2001-03-14
FR2820322A1 (fr) 2002-08-09
ATE343374T1 (de) 2006-11-15
JP2003509359A (ja) 2003-03-11
ITRM20000491A1 (it) 2002-03-11
US20040157815A1 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
ITRM20000491A0 (it) Formulazione farmaceutica di propionato di fluticasone.
NO20022998L (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
PT1221918E (pt) Administracao de drogas sub-tenon
ITTO20010008A0 (it) Formulazione farmaceutica
NO20033384L (no) Farmasoytisk formulering
DK1073417T3 (da) Farmaceutisk aerosolformulering
NO20033556D0 (no) Farmasöytiske preparater
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO20071303L (no) Farmasoytiske preparater
NO20033785D0 (no) Farmasöytisk formulering
EE200200038A (et) Konservitud farmatseutilised preparaadid
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
NO20035627D0 (no) Farmasöytisk formulering
NO20015670L (no) Forbedrede farmasöytiske formuleringer
NO20040047L (no) Farmasoytisk formulering for intramuskulaer administrering av fulvestrant
NO20014926D0 (no) Farmasöytiske forbindelser
FR2802423B1 (fr) Compositions pharmaceutiques
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
DK1227817T3 (da) Ciclesonid-holdigt vandigt farmaceutisk præparat
AR025867A1 (es) Formulacion portasdora farmaceutica
EE200100697A (et) Farmatseutiline kompleks
NO20004816D0 (no) Ny farmasøytisk formulering
GB2392164B (en) Pharmaceutical formulation of fluticasone propionate
IT1316440B1 (it) Cannula erogatrice di unguenti medicinali.
GB0312326D0 (en) Pharmaceutical formulation of fluticasone propionate